Clinical Trial Update: Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular Carcinoma [NA]

View source ↗

Summary

This clinical trial update discusses adjuvant thalidomide after curative resection of hepatocellular carcinoma; the current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Hepatocellular Carcinoma, Recurrence | NA | Status: UNKNOWN